Quantitative Estimate of CO2 Emission Reduction from Reuse of Automobile Parts in Japan

In general, reusing automobile parts reduces not only the cost of replacing the failed parts but also the environmental load of manufacturing new parts. However, these effects have not yet been quantified. The present study focuses on determining the emitted CO2 during production and quantitatively evaluating its reduction by the reuse of automobile parts. First, CO2 emissions are calculated during the reused parts production process at the factory site. Thirty-nine automobiles from 27 models prepared in Japan are examined to measure the amount of CO2 emitted in the production of new parts. Furthermore, the CO2 emission reduction effect for different automobile models is estimated through multiple regression analysis. The CO2 emissions are assumed to be the objective variable, whereas the explanatory variables are derived from the data provided in the automobile inspection certificates. The presented quantitative estimate of CO2 emission reduction owing to the exploitation of reused parts is expected to promote policies for further reducing CO2 emissions and arouse public awareness regarding the benefits of recycling automobile parts

Sorafenib-induced Prostate Volume Reduction, a New Adverse Effect Detected by Imaging: A Pilot Study

Background: Sorafenib has been used in the treatment of advanced hepatocellular carcinoma (HCC) and renal cell carcinoma (RCC). Sorafenib-associated organ reduction have been reported on imaging, such as thyroid, pancreas and muscle, but there has been no research on prostate volume reduction (PVR).Methods: We retrospectively analyzed 26 patients (twenty with HCC and six patients with RCC) who underwent sorafenib therapy for 31 to 1225 days (median, 100 days). PVR was estimated by two independent readers using CT volumetry.Results: The sum of all prostate volumes measured by reader 1 was 24.2 ± 13.8 cm3 on the baseline CT and 20.4 ± 10.6 cm3 on the follow-up CT (p < 0.001), and that measured by reader 2 was 22.3 ± 13.9 cm3 on the baseline CT and 19.2 ± 10.6 cm3 on the follow-up CT (p < 0.001). The concordance correlation coefficient for the prostate volume measured by the two readers was 0.95 on the baseline CT scans and 0.94 on the follow-up CT scans. Sorafenib-associated PVR demonstrated slight dependence to the exposure time (r = –0.23). One patient with benign prostatic hyperplasia (BPH) showed PVR (from 80.4 to 61.5 cm3 [reader 1]; 83.4 to 61.6 cm3 [reader 2]) after sorafenib administration. Sorafenib-associated PVR occurred in patients both with and without underlying liver dysfunction with relative prostate volume changes of 86.7 ± 12.0% and 85.0 ± 9.0%, respectively.Conclusion: Our study demonstrated significant PVR with sorafenib treatment in patients regardless of the presence of BPH and underlying liver dysfunction

Sorafenib-induced Prostate Volume Reduction, a New Adverse Effect Detected by Imaging: A Pilot Study

Background:  Sorafenib has been used in the treatment of advanced hepatocellular carcinoma (HCC) and renal cell carcinoma (RCC). Sorafenib-associated organ reduction have been reported on imaging, such as thyroid, pancreas and muscle, but there has been no research on prostate volume reduction (PVR). Methods:  We retrospectively analyzed 26 patients (twenty with HCC and six patients with RCC) who underwent sorafenib therapy for 31 to 1225 days (median, 100 days). PVR was estimated by two independent readers using CT volumetry. Results:  The sum of all prostate volumes measured by reader 1 was 24.2 ± 13.8 cm3 on the baseline CT and 20.4 ± 10.6 cm3 on the follow-up CT (p &lt; 0.001), and that measured by reader 2 was 22.3 ± 13.9 cm3 on the baseline CT and 19.2 ± 10.6 cm3 on the follow-up CT (p &lt; 0.001). The concordance correlation coefficient for the prostate volume measured by the two readers was 0.95 on the baseline CT scans and 0.94 on the follow-up CT scans. Sorafenib-associated PVR demonstrated slight dependence to the exposure time (r = –0.23). One patient with benign prostatic hyperplasia (BPH) showed PVR (from 80.4 to 61.5 cm3 [reader 1]; 83.4 to 61.6 cm3 [reader 2]) after sorafenib administration. Sorafenib-associated PVR occurred in patients both with and without underlying liver dysfunction with relative prostate volume changes of 86.7 ± 12.0% and 85.0 ± 9.0%, respectively. Conclusion: Our study demonstrated significant PVR with sorafenib treatment in patients regardless of the presence of BPH and underlying liver dysfunction

YETI observations of the young transiting planet candidate CVSO 30 b

CVSO 30 is a unique young low-mass system, because, for the first time, a close-in transiting and a wide directly imaged planet candidates are found around a common host star. The inner companion, CVSO 30 b, is the first possible young transiting planet orbiting a previously known weak-lined T-Tauri star. With five telescopes of the 'Young Exoplanet Transit Initiative' (YETI) located in Asia, Europe and South America we monitored CVSO 30 over three years in a total of 144 nights and detected 33 fading events. In two more seasons we carried out follow-up observations with three telescopes. We can confirm that there is a change in the shape of the fading event between different observations and that the fading event even disappears and reappears. A total of 38 fading event light curves were simultaneously modelled. We derived the planetary, stellar, and geometrical properties of the system and found them slightly smaller but in agreement with the values from the discovery paper. The period of the fading event was found to be 1.36 s shorter and 100 times more precise than the previous published value. If CVSO 30 b would be a giant planet on a precessing orbit, which we cannot confirm, yet, the precession period may be shorter than previously thought. But if confirmed as a planet it would be the youngest transiting planet ever detected and will provide important constraints on planet formation and migration time-scales.Comment: 14 pages (20 with appendix), 7 figures (16 with appendix), 6 tables (7 with appendix

Development of Gas Multiplier Counters (GMCs) Onboard the 6U CubeSat X-Ray Observatory NinjaSat

We report the development of Gas Multiplier Counters (GMCs) onboard the 6U CubeSat X-ray observatory NinjaSat, scheduled to be launched in October 2023. GMC is a 1U-size non-imaging gas X-ray detector sensitive to 2–50 keV X-rays, and two identical GMCs are mounted on NinjaSat. GMC consists of a gas cell filled with a xenon/argon/dimethyl ether (75%/24%/1%) gas mixture with a pressure of 1.2 atm at 0◦C, a high voltage supply and analog signal processing board, a digital signal processing board, an X-ray collimator of a 2.1◦ field of view, and an iron-55 calibration source. The most significant feature of the GMC is its large effective area of 32 cm2 at 6 keV, which is more than two orders of magnitude larger than the X-ray detectors onboard previously launched CubeSats. We have achieved this at a low cost and in a short development time by employing a gas detector that can easily increase its effective area and using a space-proven gas electron multiplier. GMC was characterized with X-rays from an X-ray generator in a laboratory and monochromatic X-rays on the BL-14A beamline at the KEK synchrotron radiation facility. In this paper, we present the design of GMC and the preliminary results of the detector calibration

NinjaSat: 6U CubeSat Observatory for Bright X-Ray Sources

NinjaSat is a 6U CubeSat observatory designed for long-term monitoring of bright X-ray sources, such as binary systems between normal stars and black holes or neutron stars. NinjaSat is the first Japanese CubeSat dedicated to astronomical observation, and it is also a mission to demonstrate that even a small satellite, which can be developed quickly and inexpensively, unlike large satellites, can perform excellent scientific observations. NinjaSat realizes the world’s highest X-ray sensitivity in CubeSat missions by using gas X-ray detectors filling the entire space allocated for science payloads. The fabrication of the flight model payloads began in 2021, and testing at the payload component level was completed in August 2022; as of April 2023, the payloads were integrated into the Nano Avionics 6U bus (M6P) in Lithuania. After four months of testing, the payload will be stored in the Exolaunch deployer in August and launched by the SpaceX Transporter-9 mission in October 2023. This paper will describe the scientific objectives, satellite structure, payloads, and operations of NinjaSat

Development of Radiation Belt Monitors for the 6U CubeSat X-Ray Observatory NinjaSat

NinjaSat is a 6U CubeSat-sized X-ray observatory to be launched into the low Earth orbit at an altitude of 550 km, and is scheduled for launch this October. NinjaSat is equipped with two 1U-sized gas X-ray detectors (GMC) and is expected to operate mainly for astronomical observations of bright X-ray objects in the sky, such as neutron stars and black holes. Since high voltages are applied to the gas cells of GMC, two radiation belt monitors (RBM) will also be installed to protect GMC from electrical discharges potentially caused by excessively high rate of charged particles. NinjaSat RBM will play a fail-safe function in the voltage suppression operation of GMC in the auroral zone and South Atlantic Anomaly, and also protect GMC from charged particles such as protons and electrons that arrive unexpectedly due to solar flares or other low-Earth orbit radiation events. RBM uses a 9 mm x 9 mm Si-PIN photodiode as a charged particle sensor. By taking advantage of the difference in sensor response to protons and electrons, the sensor is designed to simultaneously count charged particle rates at multiple energy thresholds so that GMC protection function will operate even if either the proton or electron rate increases. RBM can count up to about 10 kcps with almost no loss of counts, and proton beam tests have confirmed that the response performance is sufficient to protect GMC against excessively high charged particle rates above 10 Mcps without choking the circuitry. The flight models of the RBM have passed the thermal vacuum and vibration tests last year. The developed RBM occupies only about 6% of the 1U CubeSat size in volume and weighs only 70g. In addition, since the RBM uses inexpensive, commercially available sensors, it could be installed on small satellites other than NinjaSat with relatively small development resources